Search

Your search keyword '"Vidaud, Michel"' showing total 430 results

Search Constraints

Start Over You searched for: Author "Vidaud, Michel" Remove constraint Author: "Vidaud, Michel" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
430 results on '"Vidaud, Michel"'

Search Results

1. Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

2. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

3. Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes

4. Droplet Digital PCR for Fast and Accurate Characterization of NF1 Locus Deletions: Confirmation of the Predominant Maternal Origin of Type-1 Deletions

5. Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1

6. Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study

8. EZH1/2 function mostly within canonical PRC2 and exhibit proliferation-dependent redundancy that shapes mutational signatures in cancer

11. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?

12. Identification of potential common genetic modifiers of neurofibromas: a genome-wide association study in 1333 patients with neurofibromatosis type 1.

16. IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C

17. Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy

18. Bleeding in patients with Budd–Chiari syndrome

19. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

24. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer’s disease

33. Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

39. Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms

45. Liver gene expression rational to build a serum proteins signature of mild fibrosis in chronic hepatitis C: 1726

47. A liver gene molecular study rational to identify serum proteins signature to predict treatment response in chronic Hepatitis C: 1000

Catalog

Books, media, physical & digital resources